COVID-19
-
FDA Authorizes First Covid-19 and Flu Test, But Its Maker Files for Bankruptcy
Lucira Health now has the first FDA authorized diagnostic that detects the novel coronavirus and influenza in a single test. But the regulatory decision comes too late for the diagnostics developer, which has filed for bankruptcy protection.
-
Devices & Diagnostics, Sponsored Post
How to Leverage Diagnostic Development to Guard Against RSV, Flu and Covid-19
A webinar sponsored by BD scheduled for March 7 will explore how diagnostics companies are working with healthcare organizations to guard against the perfect storm of Covid-19, RSV and influenza. Register today!
-
Payer’s Place: Dr. Anil Singh
Dr. Anil Singh shares his insights into the strategies employed by the organization to identify the most effective digital solutions for their members.
-
GSK’s Covid-19 Valentine to Vir Biotech: ‘You Can Go Your Own Way’
GSK gave Vir Biotechnology a Valentine’s Day break-up message, but it’s not a complete goodbye. Though the two companies are ending their Covid-19 collaboration, they’ll still work together on other respiratory programs, including a prophylactic influenza antibody drug that is in mid-stage clinical development.
-
Aligos Trims Staff to Hone Focus on Early Clinical Programs in NASH, Covid-19
The Aligos Therapeutics pipeline reprioritization comes after clinical trial setbacks to two hepatitis B drug candidates led the biotech to end both programs. Still intact is a Merck research collaboration focused on developing NASH therapies.
-
Pharma Returns Slump as Post-Pandemic Realities Set In, Deloitte Report Says
R&D spending rose in response to Covid-19, bringing with it higher expectations for returns on all biopharma investments. The once sky-high projections are coming down to Earth, with returns now in line with pre-pandemic levels, according to a new Deloitte report.
-
Virtual Substance Use Disorder Companies Sound Alarm Over PHE Ending
The Covid-19 public health emergency waived a rule that required a practitioner to conduct an in-person medical exam before prescribing controlled substances via telemedicine. Once the public health emergency ends on May 11, those with substance use disorder could be greatly affected, experts are warning.
-
KFF: 65% of People Disenrolled from Medicaid/CHIP Went Through Period of Uninsurance
The Kaiser Family Foundation examined pre-pandemic data to determine what will happen to those disenrolled from Medicaid and CHIP once the continuous enrollment requirement ends March 31. The analysis found that 65% of those disenrolled went through a period of uninsurance.
-
Survey: Americans Are Split on the Covid-19 Public Health Emergency
About 51% of U.S. adults are in favor of the Covid-19 public health emergency still in effect, while 39% said it is no longer needed, a recent Morning Consult survey found. Americans’ opinions varied based on political party, generation, race/ethnicity and location.
-
One Simple Action Can Ease ‘Tripledemic’ Pressures: Paid Sick Leave
Nearly a quarter of private sector employees don’t have any paid sick days, according to the National Partnership for Women & Families. Providing this benefit will save employers down the line, one expert argues.
-
Discover the Next-Gen Platform for Integrated Collaborative Care
Beyond EHRs and digital front doors, reducing the gaps in patient care journeys.
-
25 Governors Pressure Biden Admin to End Public Health Emergency
In a letter addressed to President Joe Biden, 25 governors argued that the Covid-19 public health emergency should end in April. An estimated 18 million people could lose Medicaid coverage if that happens, according to a recent report.
-
Oscar Health: State of the Economy Is Top Health Concern for Consumers
An Oscar Health survey found that about 93% of respondents are “extremely,” “very” or “somewhat” concerned about the state of the economy. Another 44% of respondents listed the economy as their top healthcare concern.
-
18M Are at Risk of Losing Medicaid Coverage at the End of Covid Emergency
Of these 18 million people, 3.8 million people will become completely uninsured, according to the Urban Institute’s report. The estimate is higher than HHS’ August prediction of 15 million people losing coverage after the public health emergency.
-
Report: Employed Individuals Experience Worse Anxiety, Depression Than National Average
The report was commissioned by Wysa, a company that created an AI chatbot for mental health support. It found that 40% of working adults suffer from moderate to severe anxiety and/or depression. Many of these employees would prefer talking to an app about their struggles than someone in their workplace.
-
AHIP: Americans Want Congress To Make Telehealth Capabilities Permanent
An AHIP survey found that 73% of commercially-insured telehealth users think that Congress should make telehealth provisions permanent. These provisions were put in place to meet Americans’ needs during Covid-19.
-
MedCity Pivot Podcast: A conversation with Gilead Sciences VP Anu Osinusi
Gilead Sciences is a leader in the field of virology treatments. As VP of clinical research for hepatitis, respiratory and emerging viruses at Gilead, Anu Osinusi talked about the pharma company’s work in HIV and hepatitis and how her personal background informed her team’s work in developing a Covid-19 treatment.